Resource library

Scientific publications

Scientific publications

High Quality Imaging in Clinical Trials – Standardization mechanisms

Beaumont H - Affiliations: [1] Median Technologies, Valbonne, France

Presentation #18018479 at the Quantitative Imaging Reading Room, Annual Meeting of the Radiology Society of North America (RSNA) 2018; 2018 Nov. 25-29; Chicago, IL, USA

Can we improve cost effectiveness of oncology clinical trials workflow? A prospective RECIST 1.1 study

Hubert Beaumont [1], Antoine Iannessi [2], Catherine Klifa [1], Sebastien Patriti [2] - Affiliations: [1] Median Technologies, Valbonne, France. [2] Centre Antoine Lacassagne, Nice, France.

Poster presented at ESMO ASIA 2018, Singapore, Nov. 23 -25, 2018

Feasibility of Using Deep Learning Techniques to Assess Hepatic Fibrosis Directly from Magnetic Resonance Elastography Source Images

Marc-Michel Rohé [1], Estanislao Oubel [1], Marie-Lise Grisoni [1], Stephen Djedjos [2], Robert P. Myers [2], Hohit Loomba [3] and Michael S. Middleton [3] - Affiliations: [1] Median Technologies, Valbonne, France. [2] Gilead - [3] UCSD, San Diego, CA, USA

Scientific poster presented at The Liver Meeting® 2018 | AASLD – San Francisco (Nov. 9 – Nov. 13, 2018). Study was performed in collaboration with Gilead and the University of California San Diego (UCSD)

Reproducibility of mRECIST criteria for assessment of HCC treated by anti-VEGFR therapy: Impact of the reader's experience

Hubert Beaumont [1], Sophie Egels [2], Nathalie Faye [1], Catherine Klifa [1], Antoine Iannessi [3], Eric Bonnard [3], Olivier Lucidarme [2] -Affiliations: [1] Median Technologies, Valbonne, France. [2] Hôpital La Pitié Salpétrière, Paris, France. [3] Centre Antoine Lacassagne, Nice, France.

Poster presented at the ESMO 2018 Congress, in Munich. Study was performed in collaboration with the French Hospital La Pitie-Salpetriere (AP-HP, France) and the Antoine Lacassagne Cancer Center (Nice, France).

The NELSON triage algorithm applied to a Chinese biopsied population: A pilot study

Beaumont H [1], Hu J [2], Yang D [2], Wang N [2], Li P [2], Lu S [2], Shi W [2), Ge D [2], Faye N [1], Bai C [2]. Affiliations: [1] Median Technologies, Valbonne, France. [2] Zhongshan Hospital Fudan University, Shanghai, China.

Poster presented at the IASLC 19th World Conference of Lung Cancer, 2018 September 23-26, Toronto, Canada

Resource library